News

A new once-daily cystic fibrosis (CF) treatment trialled in Manchester has been approved for NHS use, following a recommendation made earlier this month by the National Institute for Health ...
Through our pioneering research and innovation we are improving lives by giving patients the opportunity to shape and take part in clinical studies and evaluations. Click the image below to view our ...
As part of a wider World Health Organisation goal to eliminate hepatitis C (a virus that can infect the liver), globally by 2030, NHS England is committed to eliminating hepatitis C by 2025. About the ...
Award winning Dr Fozia Ahmed is a Consultant Cardiologist at Manchester University NHS Foundation Trust (MFT). She is also the national lead and co-chair of the Global Expert Panel for STEP HFpEF – a ...
The Research and Innovation (R&I) Annual Report for 2023 – 2024: Delivering Change Together (covering 1 April 2023 to 31 March 2024) details the scope and breadth of R&I at Manchester University NHS ...
New research from Manchester University NHS Foundation Trust (MFT) and co-funded by the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC), has shown ...
North Manchester General Hospital (NMGH) is located in Crumpsall, 3.5 miles north of Manchester City Centre and is now part of the wider family of MFT hospitals creating a Single Hospital Service for ...
A ground-breaking genetic test that could prevent critically ill newborn babies going deaf if treated with gentamicin, a commonly used antibiotic, is being trialled across 14 NHS neonatal (specialist ...
This study will investigate whether the drug Ravicti is an effective treatment for a group of inherited eye conditions called bestrophinopathies. Bestrophinopathies result from faults in bestrophin, a ...
Dr Irvine Mangawa is a Clinical Research Fellow in Infectious Disease at North Manchester General Hospital (NMGH), part of MFT, and recently completed the NIHR’s Associate Principal Investigator (API) ...
How iTap works? iTap provides a Trust-wide framework to streamline NHS adoption of innovations that are market-ready. We match your solution with relevant clinical and operational teams, ensuring a ...
Patients across Greater Manchester, and the UK, will have greater access to cutting-edge treatments and clinical trials following a government announcement of £100 million of private investment to set ...